Involvement of NLRP3 inflammasome in methamphetamine-induced microglial activation through miR-143/PUMA axis

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Microglia-mediated neuroinflammation is linked to Nod-like Receptor Protein 3 (NLRP3) inflammasome activation.
• Methamphetamine induces microglial activation, but its connection to NLRP3 inflammasome remains unclear.
• The role of P53-up-regulated modulator of apoptosis (PUMA) in microglial activation is not well understood.

Purpose of the Study:

• To investigate the contribution of NLRP3 inflammasome activation to methamphetamine-induced microglial activation.
• To explore the role of PUMA in this process.
• To elucidate the regulatory pathway involving miR-143 and PUMA in methamphetamine-induced neuroinflammation.

Main Methods:

• Animal models of methamphetamine exposure.
• Assessment of NLRP3 inflammasome and microglial activation markers.
• Gain- and loss-of-function studies for PUMA and miR-143.
• Analysis of post-transcriptional regulation mechanisms.

Main Results:

• Methamphetamine induced both NLRP3 inflammasome and microglial activation.
• Downregulation of PUMA significantly inhibited microglial activation.
• Methamphetamine increased PUMA protein, not mRNA, suggesting post-transcriptional regulation by miR-143.
• miR-143 was decreased in methamphetamine-treated cells, regulated by NF-κB1.

Conclusions:

• The miR-143/PUMA pathway plays a critical role in mediating methamphetamine-induced microglial activation via NLRP3 inflammasome.
• Findings reveal a novel regulatory mechanism in drug abuse-related neuroinflammation.
• This pathway represents a potential therapeutic target for methamphetamine-induced neuroinflammation.